ArticleCureus2026
Atypical Presentation of Retrograde Cricopharyngeus Dysfunction in a Patient With Gilles de la Tourette Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retrograde cricopharyngeus dysfunction (R-CPD) is a newly classified syndrome in which a person is unable to burp, submitting them to socially debilitating symptoms of abdominal distension, gurgling noises from the throat and excessive flatulence. We discuss the case of a man in his 30s with Gilles de la Tourette syndrome, who acquires R-CPD following a period of transient dysphagia. The patient experienced years of inconclusive investigations and failed treatments before discovering the condition online and proposing it to his ENT specialist. He was treated with a botulinum toxin (BT) injection into the cricopharyngeus muscle, which showed an initial positive benefit. This case report emphasises the importance of considering R-CPD in patients presenting with similar symptoms. We discuss the diagnostic and therapeutic uses of BT and the additional challenges of a concurrent diagnosis of Tourette syndrome. The awareness of R-CPD amongst medical practitioners is vital to ensure its timely diagnosis, ultimately preventing unnecessary treatments and patient distress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.